Page last updated: 2024-08-25

doripenem and E coli Infections

doripenem has been researched along with E coli Infections in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S1
Fu, L; Li, H; Li, X; Liu, J; Luo, S; Wan, Z; Wang, Y; Wu, X; Xie, X; Zhao, Z1
Anh, ND; Chan, WM; Garcia, J; Harijanto, E; Lee, C; Loo, CM; Mustafa, M; Van Kinh, N1
Kirikae, T; Miyoshi-Akiyama, T; Shimada, K; Tada, T1
Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L1
Mariano, N; Rahal, JJ; Urban, C1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Egerman, U; Laeuffer, JM; Stucki, A1
Hayasaki, Y; Hua, YX; Izumi, K; Mikamo, H; Sato, Y; Tamaya, T1

Trials

1 trial(s) available for doripenem and E coli Infections

ArticleYear
A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study).
    International journal of antimicrobial agents, 2014, Volume: 43, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome; Urinary Tract Infections; Young Adult

2014

Other Studies

7 other study(ies) available for doripenem and E coli Infections

ArticleYear
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Academic Medical Centers; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Israel; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Time Factors

2010
In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
    Journal of global antimicrobial resistance, 2020, Volume: 20

    Topics: Acinetobacter baumannii; Administration, Intravenous; Animals; Anti-Bacterial Agents; Biofilms; Colistin; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Monte Carlo Method; Sulbactam; Treatment Outcome; Urinary Tract Infections

2020
Biochemical analysis of metallo-β-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Japan; Microbial Sensitivity Tests; Plasmids

2014
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States

2017
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin

2010
Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Cefepime; Cephalosporins; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Rabbits; Treatment Outcome

2012
In vitro and in vivo antibacterial activities of a new injectable carbapenem, S-4661, against gynaecological pathogens.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Rats; Uterine Diseases

2000